Steerable Sheath for Vascular Systems

The sheath has received the CE Mark, opening the way for marketing the device in Europe.

The sheath was developed by Enpath Medical (Minneapolis, MN, USA; www.enpathmed.com) for electrophysiology (EP) applications, and is a tool that facilitates the placement of interventional devices in the peripheral, coronary, and neurovascular systems. It features distal tip deflection to aid in the precise placement of such devices as cardiac ablation catheters and peripheral stent delivery catheters. Other applications are the delivery of carotid artery stents and other peripheral vessel interventions, as well as precision placement of implantable leads.

"With the U.S. Food and Drug Administration (FDA) clearance received in July, 2005, the European Union's approval positions Enpath's innovative steerable sheath for distribution in the two largest electrophysiology markets in the world,” said Jim Hartman, chairman and chief executive officer of Enpath Medical.




Related Links:
Enpath Medical